Patent · US Active

Quinazolinone derivatives as PARP inhibitors

US10150757B2 · kind B2 · utility

0Cited by

19References

7Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Jérôme Emile Georges Guillemont · Andé, FR
Ludo Edmond Josephine Kennis · Lier, BE
Josephus Carolus Mertens · Oud-Turnhout, BE
Jacobus Alphonsus Josephus Van Dun · Kasterlee, BE
Maria Victorina Francisca Somers · Vosselaar, BE
Walter Boudewijn Leopold Wouters · Kapellen, BE

Key dates

Filing date	Nov 14, 2016
Grant date	Dec 11, 2018
Priority date	—
Expiry date	Nov 14, 2036

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides compounds of formula (I), their use as PARP inhibitors as well as pharmaceutical compositions comprising said compounds of formula (I) wherein R1, R2, R3, L, X, Y and Z have defined meanings.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.